Home › COPD › Tennessee › Chattanooga
COPD clinical trials in Chattanooga, TN
3 studies for COPD are looking for participants at sites in and around Chattanooga (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, Chattanooga
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Chattanooga Research and Medicine- Site Number : 8400026, Chattanooga
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
- Research Site, Chattanooga
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA23 studies
- Miami, FL18 studies
- Birmingham, AL17 studies
- Boston, MA17 studies
- Houston, TX15 studies
- Orlando, FL15 studies
- Baltimore, MD14 studies
- Chicago, IL14 studies
- Dallas, TX12 studies
- Pittsburgh, PA12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
Other studies in Chattanooga
- Non-Small Cell Lung Cancer11 studies
- Myasthenia Gravis6 studies
- Metastatic Cancer6 studies
- Ovarian Cancer5 studies
- Steatotic Liver Disease4 studies
- Chronic Kidney Disease4 studies
- Lung Cancer4 studies
- Ischemic Stroke4 studies
- Melanoma4 studies
- Diabetes4 studies
- Colorectal Cancer4 studies
- Endometrial Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.